Ligand validation:6MN5

EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6MN5_EPE_B_303	68%	24%	0.163	0.976	2.04	1.1	1	3	2	0	100%	1
6MN5_EPE_C_304	64%	24%	0.163	0.964	2.03	1.12	1	3	3	0	100%	1
6MN5_EPE_D_303	64%	24%	0.168	0.969	2.04	1.1	1	3	0	0	100%	1
6MN5_EPE_B_304	62%	24%	0.164	0.957	2.03	1.1	1	3	0	0	100%	1
6MN5_EPE_E_303	52%	24%	0.193	0.952	2.02	1.1	1	3	0	0	100%	1
6MN5_EPE_F_303	52%	24%	0.204	0.962	2.04	1.1	1	3	1	0	100%	1
6MN5_EPE_C_303	49%	24%	0.199	0.948	2.03	1.09	1	3	1	0	100%	1
6MN5_EPE_A_304	46%	24%	0.211	0.946	2.04	1.1	1	3	0	0	100%	1
6MN5_EPE_A_303	44%	24%	0.224	0.954	2.04	1.1	1	3	1	0	100%	1
6MN5_EPE_E_304	40%	24%	0.226	0.94	2.03	1.09	1	3	0	0	100%	1
6MN5_EPE_D_304	40%	24%	0.228	0.94	2.04	1.1	1	3	1	0	100%	1
6MN5_EPE_F_304	35%	24%	0.238	0.928	2.03	1.1	1	3	0	0	100%	1
6MN4_EPE_C_304	65%	37%	0.165	0.967	0.78	1.68	1	6	2	0	100%	1
4WX4_EPE_A_302	99%	53%	0.064	0.994	0.99	0.82	1	-	0	0	100%	1
2F9R_EPE_B_701	99%	44%	0.061	0.989	0.62	1.54	-	2	0	0	100%	1
1VSI_EPE_A_261	98%	15%	0.058	0.984	1.64	2.09	1	6	1	0	100%	1
1XX1_EPE_D_2004	98%	31%	0.063	0.987	0.79	1.91	1	5	1	0	100%	1
4WYD_EPE_B_503	98%	44%	0.065	0.989	0.93	1.23	1	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.